Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-08-2019 | Original Paper

12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany

Authors: Sven Speerforck, F. Dodoo-Schittko, S. Brandstetter, C. Apfelbacher, U. Hapke, F. Jacobi, H. J. Grabe, S. E. Baumeister, G. Schomerus

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 5/2019

Abstract

Background

Major depressive disorder (MDD) and bipolar disorder are associated with certain cardiovascular risk factors (CVRFs), but it is unclear whether they are associated with unfavourable changes of clinically manifest CVRFs over time.

Methods

We used baseline and 12-year follow-up (n = 1887) data from the German Health Interview and Examination Survey 1998. Multivariable linear regression models assessed associations between lifetime CIDI-diagnosed mood disorders at baseline and continuous risk factor-related outcomes (blood pressure, HbA1c, LDL-C, HDL-C, triglycerides, BMI) at follow-up.

Results

We did not find consistent deterioration of CVRFs in persons with compared to persons without MDD. Analyses pointed to severity of mood disorder as an important correlate of long-term changes of comorbid hypertension: while a history of mild MDD was not associated with changes in CVRFs, moderate MDD was associated with lower blood pressure [systolic: β = − 7.5 (CI − 13.2; − 1.9); diastolic: β = − 4.5 (CI − 7.8; − 1.3)] and a history of bipolar disorder was associated with higher systolic blood pressure at follow-up (β = 14.6; CI 4.9–24.4). Further, severe MDD was weakly associated with a higher BMI at follow-up [β = 1.2 (CI 0.0; 2.4)]. These outcomes were not mediated by use of psychotropic medication and remained statistically significant after adjusting for the use of antihypertensive medication.

Conclusion

Since most investigated parameters showed no associations, participants with a lifetime history of MDD in this cohort did not carry a specific risk for a worsening of pre-existing clinically manifest CVRFs. Our findings extend evidence of MDD severity and bipolar disorder as important correlates of long-term changes of arterial hypertension and obesity.

Available only for authorised users

Jacobi F, Wittchen H-U, Holting C et al (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 34(4):597–611. https://doi.org/10.1017/S0033291703001399 CrossRefPubMed

Luck T, Then FS, Engel C et al (2017) Die Prävalenz aktueller depressiver Symptomatik in einer urbanen Erwachsenenpopulation (The prevalence of current depressive symptoms in an urban adult population). Psychatr Prax 44(3):148–153. https://doi.org/10.1055/s-0041-111428 CrossRef

Chesney E, Goodwin GM, Fazel S (2014) Risks of all-cause and suicide mortality in mental disorders: a meta-review. World psychiatry 13(2):153–160. https://doi.org/10.1002/wps.20128 CrossRefPubMedPubMedCentral

Nordentoft M, Wahlbeck K, Hällgren J et al (2013) Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 8(1):e55176. https://doi.org/10.1371/journal.pone.0055176 CrossRefPubMedPubMedCentral

Brown JM, Stewart JC, Stump TE et al (2011) Risk of coronary heart disease events over 15 years among older adults with depressive symptoms. Am J Geriatr Psychiatry 19(8):721–729. https://doi.org/10.1097/JGP.0b013e3181faee19 CrossRefPubMedPubMedCentral

Goldstein BI, Fagiolini A, Houck P et al (2009) Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 11(6):657–662. https://doi.org/10.1111/j.1399-5618.2009.00735.x CrossRefPubMedPubMedCentral

Rugulies R (2002) Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 23(1):51–61CrossRefPubMed

Brunner EJ, Shipley MJ, Britton AR et al (2014) Depressive disorder, coronary heart disease, and stroke: dose–response and reverse causation effects in the Whitehall II cohort study. Eur J Prev Cardiol 21(3):340–346. https://doi.org/10.1177/2047487314520785 CrossRefPubMed

Whooley MA, Jonge P de, Vittinghoff E et al (2008) Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300(20):2379–2388. https://doi.org/10.1001/jama.2008.711 CrossRefPubMedPubMedCentral

10.

Goldstein BI, Carnethon MR, Matthews KA et al (2015) Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation 132(10):965–986. https://doi.org/10.1161/CIR.0000000000000229 CrossRefPubMed

11.

Stapelberg NJC, Neumann DL, Shum DHK et al (2011) A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Aust NZ J Psychiatr 45(5):351–369. https://doi.org/10.3109/00048674.2011.570427 CrossRef

12.

Vancampfort D, Correll CU, Wampers M et al (2014) Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med 44(10):2017–2028. https://doi.org/10.1017/S0033291713002778 CrossRefPubMed

13.

Vancampfort D, Mitchell AJ, Hert M de et al (2015) Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors. Depress Anxiety 32(10):763–773. https://doi.org/10.1002/da.22387 CrossRefPubMed

14.

Silarova B, Giltay EJ, Van R Dortland, Arianne et al (2015) Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls. J Psychosom Res 78(4):391–398. https://doi.org/10.1016/j.jpsychores.2015.02.010 CrossRefPubMed

15.

Vancampfort D, Vansteelandt K, Correll CU et al (2013) Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 170(3):265–274. https://doi.org/10.1176/appi.ajp.2012.12050620 CrossRefPubMed

16.

Johannessen L, Strudsholm U, Foldager L et al (2006) Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord 95(1–3):13–17. https://doi.org/10.1016/j.jad.2006.03.027 CrossRefPubMed

17.

Kilbourne AM, Cornelius JR, Han X et al (2004) Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 6(5):368–373. https://doi.org/10.1111/j.1399-5618.2004.00138.x CrossRefPubMed

18.

Valkanova V, Ebmeier KP (2013) Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry 73(5):406–413. https://doi.org/10.1016/j.biopsych.2012.10.028 CrossRefPubMed

19.

Jansen K, Campos Mondin T, Azevedo Cardoso, Td et al (2013) Quality of life and mood disorder episodes. Community sample. J Affect Disord 147(1–3):123–127. https://doi.org/10.1016/j.jad.2012.10.021 CrossRefPubMed

20.

Ösby U, Westman J, Hällgren J et al (2016) Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010. Eur J Public Health 26(5):867–871. https://doi.org/10.1093/eurpub/ckv245 CrossRefPubMedPubMedCentral

21.

Fiedorowicz JG, Solomon DA, Endicott J et al (2009) Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 71(6):598–606. https://doi.org/10.1097/PSY.0b013e3181acee26 CrossRefPubMedPubMedCentral

22.

Hayes JF, Marston L, Walters K et al (2017) Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014. Br J Psychiatr. https://doi.org/10.1192/bjp.bp.117.202606 CrossRef

23.

Bellach B-M, Knopf H, Thefeld W (1998) Der Bundes–Gesundheitssurvey 1997/98. Gesundheitswesen 60(Sonderheft 2):59–68

24.

Jacobi F, Wittchen HU, Holting C et al (2002) Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res 11(1):1–18CrossRefPubMed

25.

Wittchen HU (1994) Reliability and validity studies of the WHO—Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28(1):57–84CrossRefPubMed

26.

Scheidt-Nave C, Kamtsiuris P, Gößwald A et al (2012) German health interview and examination survey for adults (DEGS)—design, objectives and implementation of the first data collection wave. BMC Public Health 12(1):730. https://doi.org/10.1186/1471-2458-12-730 CrossRefPubMedPubMedCentral

27.

Wittchen H-U, Pfister H (1997) DIA-X-Interviews: Manual für Screening-Verfahren und Interview; Interviewheft

28.

WHO Collaborating Centre for Drug Statistics Methodology (2010) Guidelines for ATC classification and DDD assignment

29.

Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2 CrossRefPubMed

30.

American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Supplement_1):S62–S67. https://doi.org/10.2337/dc09-S062 CrossRef

31.

National Cholesterol Education Program (NCEP) Expert Panel (2002) Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106(25):3143–3421CrossRef

32.

World Health Organisation (WHO) (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894(i–xii):1–253

33.

Tobin MD, Sheehan NA, Scurrah KJ et al (2005) Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 24(19):2911–2935. https://doi.org/10.1002/sim.2165 CrossRefPubMed

34.

Licht CMM, de Geus EJC, Penninx BWJH (2013) Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab 98(6):2484–2493. https://doi.org/10.1210/jc.2012-3104 CrossRefPubMed

35.

Cui JS, Hopper JL, Harrap SB (2003) Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension (Dallas Tex 1979) 41(2):207–210CrossRef

36.

Mihaylova B, Emberson J, Blackwell L et al (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380(9841):581–590. https://doi.org/10.1016/S0140-6736(12)60367-5 CrossRefPubMed

37.

Wu J, Province MA, Coon H et al (2007) An investigation of the effects of lipid-lowering medications. Genome-wide linkage analysis of lipids in the HyperGEN study. BMC Genet 8:60. https://doi.org/10.1186/1471-2156-8-60 CrossRefPubMedPubMedCentral

38.

Jun M, Foote C, Lv J et al (2010) Effects of fibrates on cardiovascular outcomes. A systematic review and meta-analysis. Lancet 375(9729):1875–1884. https://doi.org/10.1016/S0140-6736(10)60656-3 CrossRefPubMed

39.

Esposito K, Chiodini P, Bellastella G et al (2012) Proportion of patients at HbA1c target < 7% with eight classes of antidiabetic drugs in type 2 diabetes. Systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab 14(3):228–233. https://doi.org/10.1111/j.1463-1326.2011.01512.x CrossRefPubMed

40.

VanderWeele TJ, Shpitser I (2011) A new criterion for confounder selection. Biometrics 67(4):1406–1413. https://doi.org/10.1111/j.1541-0420.2011.01619.x CrossRefPubMedPubMedCentral

41.

Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702–706. https://doi.org/10.1093/aje/kwh090 CrossRefPubMed

42.

Seaman SR, White IR (2013) Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 22(3):278–295. https://doi.org/10.1177/0962280210395740 CrossRefPubMed

43.

Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001:1165–1188

44.

Newson RB (2010) Frequentist q-values for multiple-test procedures. Stat J 10(4):568CrossRef

45.

Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100(16):9440–9445. https://doi.org/10.1073/pnas.1530509100 CrossRefPubMedPubMedCentral

46.

Wulsin LR, Singal BM (2003) Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 65(2):201–210CrossRefPubMed

47.

Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27(23):2763–2774. https://doi.org/10.1093/eurheartj/ehl338 CrossRefPubMed

48.

Penninx BWJH, Beekman ATF, Honig A et al (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58(3):221–227. https://doi.org/10.1001/archpsyc.58.3.221 CrossRefPubMed

49.

Thamm M (1999) Blutdruck in Deutschland—Zustandsbeschreibung und Trends. Gesundheitswesen 61(Sonderheft 2):90–93

50.

Thefeld W (1999) Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands. Gesundheitswesen 61(Sonderheft 2):85–89

51.

Tóth PP, Potter D, Ming EE (2012) Prevalence of lipid abnormalities in the United States. The National Health and Nutrition Examination Survey 2003–2006. J Clin Lipidol 6(4):325–330. https://doi.org/10.1016/j.jacl.2012.05.002 CrossRefPubMed

52.

Bergmann KE, Mensink GBM (1999) Anthropometric data and overweight. Das Gesundheitswesen 61(Sonderheft 2(Schwerpunktheft zum Bundesgesundheitssurvey 1998)):115–120

53.

Shinn EH, Poston WSC, Kimball KT et al (2001) Blood pressure and symptoms of depression and anxiety: a prospective study*. Am J Hypertens 14(7):660–664. https://doi.org/10.1016/S0895-7061(01)01304-8 CrossRefPubMed

54.

Yan LL, Liu K, Matthews KA et al (2003) Psychosocial factors and risk of hypertension: the coronary artery risk development in young adults (CARDIA) study. JAMA 290(16):2138–2148. https://doi.org/10.1001/jama.290.16.2138 CrossRefPubMed

55.

Hildrum B, Mykletun A, Stordal E et al (2007) Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study. J Epidemiol Commun Health 61(1):53–58. https://doi.org/10.1136/jech.2005.044966 CrossRef

56.

Licht CMM, Geus EJCD, Seldenrijk A et al (2009) Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 53(4):631–638. https://doi.org/10.1161/HYPERTENSIONAHA.108.126698 CrossRefPubMed

57.

Pilgrim JA, Stansfeld S, Marmot M (1992) Low blood pressure, low mood? BMJ 304(6819):75–78. https://doi.org/10.1136/bmj.304.6819.75 CrossRefPubMedPubMedCentral

58.

Hildrum B, Mykletun A, Holmen J et al (2008) Effect of anxiety and depression on blood pressure: 11-year longitudinal population study. Br J Psychiatr 193(2):108–113. https://doi.org/10.1192/bjp.bp.107.045013 CrossRef

59.

Paterniti S, Verdier-Taillefer M-H, Geneste C et al (2000) Low blood pressure and risk of depression in the elderly. Br J Psychiatr 176(5):464–467. https://doi.org/10.1192/bjp.176.5.464 CrossRef

60.

Mojtabai R, Olfson M, Mechanic D (2002) Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry 59(1):77–84. https://doi.org/10.1001/archpsyc.59.1.77 CrossRefPubMed

61.

Nabi H, Chastang J-F, Lefèvre T et al (2011) Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study. Hypertension 57(4):710–716. https://doi.org/10.1161/HYPERTENSIONAHA.110.164061 CrossRefPubMed

62.

Davidson K, Jonas BS, Dixon KE et al (2000) Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Arch Intern Med 160(10):1495–1500. https://doi.org/10.1001/archinte.160.10.1495 CrossRefPubMed

63.

Gangwisch JE, Malaspina D, Posner K et al (2010) Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am J Hypertens 23(1):62–69. https://doi.org/10.1038/ajh.2009.202 CrossRefPubMed

64.

Jonas BS, Lando JF (2000) Negative affect as a prospective risk factor for hypertension. Psychosom Med 62(2)

65.

Patten SB, Williams JV, Lavorato DH et al (2009) Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med 71(3):273–279. https://doi.org/10.1097/PSY.0b013e3181988e5f CrossRefPubMed

66.

Lamers F, Beekman ATF, van Hemert AM et al (2016) Six-year longitudinal course and outcomes of subtypes of depression. Br J Psychiatr 208(1):62–68. https://doi.org/10.1192/bjp.bp.114.153098 CrossRef

67.

Luppino FS, de Wit LM, Bouvy PF et al (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67(3):220–229. https://doi.org/10.1001/archgenpsychiatry.2010.2 CrossRefPubMed

68.

Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160(21):3278–3285. https://doi.org/10.1001/archinte.160.21.3278 CrossRefPubMed

69.

Fisher L, Mullan JT, Arean P et al (2010) Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 33(1):23–28. https://doi.org/10.2337/dc09-1238 CrossRefPubMed

70.

Georgiades A, Zucker N, Friedman KE et al (2007) Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 69(3):235–241. https://doi.org/10.1097/PSY.0b013e318042588d CrossRefPubMed

71.

Smits JAJ, Rosenfield D, Mather AA et al (2010) Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample. J Psych Res 44(15):1010–1016. https://doi.org/10.1016/j.jpsychires.2010.04.007 CrossRef

72.

Glaus J, Vandeleur C, Gholam-Rezaee M et al (2013) Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population. Acta Psychiatr Scand 128(4):282–293. https://doi.org/10.1111/acps.12057 CrossRefPubMed

73.

Lamers F, Vogelzangs N, Merikangas KR et al (2013) Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 18(6):692–699. https://doi.org/10.1038/mp.2012.144 CrossRefPubMed

74.

Cizza G, Ronsaville DS, Kleitz H et al (2012) Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women. The power study. PLoS One 7(1):e28912. https://doi.org/10.1371/journal.pone.0028912 CrossRefPubMedPubMedCentral

75.

Takeuchi T, Nakao M, Kachi Y et al (2013) Association of metabolic syndrome with atypical features of depression in Japanese people. Psychiatry Clin Neurosci 67(7):532–539. https://doi.org/10.1111/pcn.12104 CrossRefPubMed

76.

Lasserre AM, Strippoli M-PF, Glaus J et al (2017) Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population. Mol Psychiatry 22(7):1026–1034. https://doi.org/10.1038/mp.2016.178 CrossRefPubMed

77.

McEwen BS (2003) Mood disorders and allostatic load. Biol Psychiatry 54(3):200–207CrossRefPubMed

Title: 12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany
Authors: Sven Speerforck
F. Dodoo-Schittko
S. Brandstetter
C. Apfelbacher
U. Hapke
F. Jacobi
H. J. Grabe
S. E. Baumeister
G. Schomerus
Publication date: 01-08-2019
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue 5/2019
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-018-0923-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2019

Aerobic exercise in mental disorders: from basic mechanisms to treatment recommendations

Effects of exercise-based interventions in severe mental illness: a feasibility study

Sports psychiatry: mental health and mental disorders in athletes and exercise treatment of mental disorders

The effect of physical activity in an alpine environment on quality of life is mediated by resilience in patients with psychosomatic disorders and healthy controls

It can’t hurt, right? Adverse effects of psychotherapy in patients with depression